Influenza virus vaccine trivalent - Kaketsuken

Drug Profile

Influenza virus vaccine trivalent - Kaketsuken

Alternative Names: KD-FLU (TIV); Trivalent inactivated influenza virus vaccine - Kaketsuken

Latest Information Update: 02 Jun 2016

Price : $50

At a glance

  • Originator Kaketsuken
  • Class Influenza virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Influenza virus infections

Most Recent Events

  • 02 Jun 2016 Discontinued - Phase-II/III for Influenza virus infections prevention (In children) in Japan (SC) before June 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top